Acupuncture Versus Placebo Acupuncture During In Vitro Fertilization (IVF) Embryo Transfer
1 other identifier
interventional
635
1 country
1
Brief Summary
During IVF treatment, acupuncture at the time of embryo transfer may improve the pregnancy rate. This study aims to compare IVF pregnancy between two groups of patients that received either acupuncture or sham acupuncture (placebo)around embryo transfer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 3, 2009
CompletedFirst Posted
Study publicly available on registry
June 4, 2009
CompletedJune 4, 2009
November 1, 2005
1.3 years
June 3, 2009
June 3, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy rate
2005-2008
Study Arms (2)
1
EXPERIMENTAL30 minutes of acupuncture just before and just after embryo replacement
2
PLACEBO COMPARATORSham acupuncture for 30 minutes just before and just after embryo transfer
Interventions
The acupuncture points were chosen according to traditional Chinese medicine and included DU20, M29, KS6, Mp8, and Le3 before embryo transfer and DU20, Co4, Mp10, M36, and Mp6 after embryo transfer.
The acupuncture points were the same as in the true acupuncture group, namely DU20, M29, KS6, Mp8, and Le3 before embryo transfer and DU20, Co4, Mp10, M36, and Mp6 after embryo transfer. Sham acupuncture needles used were the validated Strietberger® placebo-needle from the company, Asia Med. The needle is not fixed inside the copper handle and its tip is blunt. When the needle touches the skin it moves inside the handle and appears to be shortened. A pricking sensation is felt by the patient, simulating the puncturing of the skin. Developed by dr. Konrad Streitberger.
Eligibility Criteria
You may qualify if:
- infertility
- below 38 years
- ivf or icsi treatment
- fresh embryo transfer cycle
- no more than two earlier embryo transfers with "fresh" embryos
- embryo transfer on day 2 or 3 after oocyte aspiration, single or double embryo transfer
You may not qualify if:
- Frozen embryo transfer
- oocyte donation
- other "alternative" treatment during the cycle
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Fertility Clinic, Copenhagen University Hospital, Denmark
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorthe Andersen, Study nurse
The Fertility Clinic, Copenhagen University Hospital Rigshospitalet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 3, 2009
First Posted
June 4, 2009
Study Start
November 1, 2005
Primary Completion
March 1, 2007
Study Completion
March 1, 2009
Last Updated
June 4, 2009
Record last verified: 2005-11